Aurora Biopharma
Cambridge, US · Founded 2015 · Delaware corporation
Founders & leadership
RB
Robert BrooksExecutive
Reported raises · per SEC filings
Form D private placements$440K disclosed across 2 rounds · 2015–2016
▶$100KraisedDec 2016 · 1 investors · BiotechnologyRule 506(b)
▶$100KraisedDec 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert BrooksExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $100K
- Minimum investment
- $25K
- Proceeds to insiders
- $5K
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$340KraisedDec 2016 · 6 investors · BiotechnologyRule 506(b)
▶$340KraisedDec 2016 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert BrooksExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $340K
- Minimum investment
- $25K
- Proceeds to insiders
- $60K
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Aurora Biopharma raised?
- Aurora Biopharma has disclosed $440K raised across 2 rounds.
- Where is Aurora Biopharma headquartered?
- Aurora Biopharma is headquartered in Cambridge, US.